[HTML][HTML] Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?

CL Stewart, S Warner, K Ito, M Raoof… - Current problems in …, 2018 - ncbi.nlm.nih.gov
Colorectal cancer commonly metastasizes. The liver is the most frequent site of metastases
and dominates the length of survival for this disease. As surgical and systemic therapies …

Recent updates in the surgical treatment of colorectal cancer

T Matsuda, K Yamashita, H Hasegawa… - Annals of …, 2018 - Wiley Online Library
Because of recent advances in medical technology and new findings of clinical trials,
treatment options for colorectal cancer are evolutionally changing, even in the last few years …

Who should get lateral pelvic lymph node dissection after neoadjuvant chemoradiation?

S Malakorn, Y Yang, BK Bednarski… - Diseases of the Colon …, 2019 - journals.lww.com
BACKGROUND: Despite the use of neoadjuvant chemoradiation and total mesorectal
excision for rectal cancer, lateral pelvic lymph node recurrence is still an important problem …

Identification of metastatic lymph nodes in MR imaging with faster region-based convolutional neural networks

Y Lu, Q Yu, Y Gao, Y Zhou, G Liu, Q Dong, J Ma, L Ding… - Cancer research, 2018 - AACR
MRI is the gold standard for confirming a pelvic lymph node metastasis diagnosis.
Traditionally, medical radiologists have analyzed MRI image features of regional lymph …

[HTML][HTML] Application of indocyanine green-enhanced near-infrared fluorescence-guided imaging in laparoscopic lateral pelvic lymph node dissection for middle-low …

SC Zhou, YT Tian, XW Wang, CD Zhao… - World journal of …, 2019 - ncbi.nlm.nih.gov
BACKGROUND As one effective treatment for lateral pelvic lymph node (LPLN) metastasis
(LPNM), laparoscopic LPLN dissection (LPND) is limited due to the complicated anatomy of …

Radiomics approach outperforms diameter criteria for predicting pathological lateral lymph node metastasis after neoadjuvant (chemo) radiotherapy in advanced low …

R Nakanishi, T Akiyoshi, S Toda, Y Murakami… - Annals of surgical …, 2020 - Springer
Background Advanced low rectal cancer has a non-negligible risk of lateral pelvic lymph
node (LPLN) metastasis (LPLNM) and lateral local recurrence (LR) after neoadjuvant …

Optimal size criteria for lateral lymph node dissection after neoadjuvant chemoradiotherapy for rectal cancer

K Kawai, H Shiratori, K Hata, H Nozawa… - Diseases of the Colon …, 2021 - journals.lww.com
BACKGROUND: Although chemoradiotherapy followed by radical surgery without lateral
lymph node dissection is the current standard treatment in patients with rectal cancer, recent …

Magnetic resonance imaging directed surgical decision making for lateral pelvic lymph node dissection in rectal cancer after total neoadjuvant therapy (TNT)

O Peacock, N Manisundaram, SR Dibrito, Y Kim… - Annals of …, 2022 - journals.lww.com
Objective: Lateral pelvic lymph node (LPLN) metastases are an important cause of
preventable local failure in rectal cancer. The aim of this study was to evaluate clinical and …

[HTML][HTML] Artificial intelligence and radiomics in magnetic resonance imaging of rectal cancer: A review

G Di Costanzo, R Ascione, A Ponsiglione… - … of Targeted Anti …, 2023 - ncbi.nlm.nih.gov
Rectal cancer (RC) is one of the most common tumours worldwide in both males and
females, with significant morbidity and mortality rates, and it accounts for approximately one …

[HTML][HTML] Lateral pelvic lymph node dissection after neoadjuvant chemoradiotherapy in patients with rectal cancer: a single-center experience and literature review

MC Kim, JH Oh - Annals of Coloproctology, 2021 - ncbi.nlm.nih.gov
Purpose We aimed to evaluate the surgicopathological outcomes of lateral pelvic lymph
node dissection (LPLD) and long-term oncological outcomes of selective LPLD after …